CompletedPhase 4

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

United States40 participantsStarted 2017-07-20

Plain-language summary

This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patient must meet 1987 ACR criteria
. Age \> 18 years of age
. Baseline DAS28/Erythrocyte Sedimentation Rate (ESR) \>=3.2
. Stable concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs)
. Stable prednisone \<10mg or equivalent
. Power Doppler score of \>=10

Exclusion criteria

. Prior treatment with Acthar in the past 2mos
. Meet one of the above RA flare requirements
. Subjects who have received live or live attenuated vaccines within 6 weeks prior to the first dose of study drug (or the zoster vaccine)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Ultrasound Power Doppler Score

Timeframe: Baseline to 2 Weeks

DAS28

Timeframe: Baseline to 2 Weeks

Trial details

NCT IDNCT02541955

SponsorVeena Ranganath, MD, MS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-06

View on ClinicalTrials.gov More Rheumatoid Arthritis (RA) trials